Social networks
1,079Activities
Entity types
Location
Hôpital Necker-Enfants Malades, 149 Rue de Sèvres, 75743 Paris, France
Paris
France
Employees
Scale: 2-10
Estimated: 5
SIREN
970808911Engaged corporates
10Added in Motherbase
5 years, 3 months ago[Automatic translation follows] NeuroSphinx coordinates all stakeholders in the management of rare pelvic and spinal cord malformations.
The Rare Disease Health Sectors are structures for coordinating stakeholders around a group of rare diseases.
Created in 2014 as part of the 2nd National Rare Disease Plan, their objective is to contribute to structuring the provision of care.
The NeuroSphinx Rare Disease Health Sector coordinates stakeholders specializing in rare pelvic and spinal cord malformations and their consequences, including incontinence disorders.
These are mainly rare diseases such as Spina Bifida, or rare anorectal and pelvic malformations or syringomyelia and Chiari malformations.
The NeuroSphinx Rare Diseases Health Sector is made up of 3 Rare Diseases Reference Centers: C-MAVEM, MAREP and MARVU.
NeuroSphinx coordonne tous les acteurs de la prise en charge des malformations pelviennes et médullaires rares.
Les Filières de santé Maladies rares sont des structures de coordination d’acteurs autour d’un groupe de maladies rares.
Créées en 2014 dans le cadre du 2e Plan National Maladies Rares, elles ont pour objectif de contribuer à structurer l’offre de soins.
La Filière de santé Maladies rares NeuroSphinx coordonne les acteurs spécialisés dans les malformations pelviennes et médullaires rares et leurs conséquences, notamment les troubles de l’incontinence.
Il s’agit principalement de maladies rares telles que le Spina Bifida, ou les malformations ano-rectales et pelviennes rares ou encore les syringomyélies et malformations de chiari.
La Filière de santé Maladies rares NeuroSphinx est composée de 3 Centres de Références Maladies rares : C-MAVEM, MAREP et MARVU.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
ANSM Agence nationale de sécurité du médicament et des produits de santé | Other 23 Mar 2023 | | ||
Ministère de la Santé | Other 9 Sep 2024 | | ||
Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Other 22 Feb 2023 | | |
Ipsen Pharmaceutical, Pharmaceutical Manufacturing | Ipsen Pharmaceutical, Pharmaceutical Manufacturing | Other 22 Feb 2023 | | |
Institut Analgesia Research, Think Tanks | Institut Analgesia Research, Think Tanks | Other 15 Oct 2022 | | |
Gustave Roussy Health, Hospitals and Health Care | Gustave Roussy Health, Hospitals and Health Care | Other 26 Sep 2022 | | |
Institut Curie Health, Hospitals and Health Care | Institut Curie Health, Hospitals and Health Care | Other 26 Sep 2022 | | |
Région Nouvelle-Aquitaine National and local authorities, Government Administration | Région Nouvelle-Aquitaine National and local authorities, Government Administration | Other 1 Dec 2022 | | |
Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Not partnership Event 22 Feb 2023 | | |
Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Not capitalistic Not partnership Event 19 Nov 2024 | |